Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) ...
Decider spoke to the Knives Out 3 cinematographer, production designer, and composer about the film’s stand-out scenes.